Aurora Spine Corporation

Equities

ASG

CA05206X1087

Medical Equipment, Supplies & Distribution

Delayed Toronto S.E. Other stock markets 12:18:20 2024-04-18 pm EDT			5-day change	1st Jan Change
0.3 ^CAD	0.00%		0.00%	-25.00%

Mar. 20	Aurora Spine on 2nd Anniversary of Implantation of First Bone Density Matched DEXA-C Cervical Interbody Fusion Device	MT
Feb. 05	Aurora Spine's Second Patent Related To DEXA Technology Patient-Matched Implant Technology Issued by U.S. Patent Office	MT

Aurora Spine Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021

November 14, 2021

Aurora Spine Corporation reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was USD 2.89 million compared to USD 2.37 million a year ago. Net loss was USD 0.368217 million compared to net income of USD 0.336163 million a year ago.
For the nine months, sales was USD 7.58 million compared to USD 6.21 million a year ago. Net loss was USD 1.46 million compared to USD 0.189905 million a year ago. Basic loss per share from continuing operations was USD 0.03.

Latest news about Aurora Spine Corporation

Aurora Spine on 2nd Anniversary of Implantation of First Bone Density Matched DEXA-C Cervical Interbody Fusion Device	Mar. 20	MT
Aurora Spine's Second Patent Related To DEXA Technology Patient-Matched Implant Technology Issued by U.S. Patent Office	Feb. 05	MT
Aurora Spine Corp Granted New US Patent	Jan. 29	MT
Aurora Spine Corporation to Showcase Sacroiliac Joint (Si Joint) Fusion Products At North American Neuromodulation Society Annual Meeting	Jan. 18	CI
Aurora Spine Corp Announces Published Paper on First 6-month Clinical Evaluation of its ZIP Fusion Implant	Dec. 04	MT
Aurora Spine Corporation Announces Newly Published Paper on First 6-Month Clinical Evaluation of its ZIP?? Fusion Implant	Dec. 04	CI
Aurora Spine Corp Announces Q3 2023 Results	Nov. 15	MT
Transcript : Aurora Spine Corporation, Q3 2023 Earnings Call, Nov 15, 2023	Nov. 15
Aurora Spine Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Aurora Spine Corporation announced that it has received CAD 1.933782 million in funding	23-10-22	CI
Aurora Spine Announces Full Release of its SiLO TFX MIS Sacroiliac Joint Fixation System	23-09-13	MT
Aurora Spine Corporation Announces Full Release of its SiLO TFX?? MIS Sacroiliac Joint Fixation System	23-09-13	CI
Transcript : Aurora Spine Corporation, Q2 2023 Earnings Call, Aug 29, 2023	23-08-29
Aurora Spine Reports Q2 2023 Net Loss of US$0.01 Per Share	23-08-23	MT
Aurora Spine Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22	CI
Aurora Spine Up After Announcing Initial Patient Enrolled for DEXA-CTM Multicenter Study	23-06-28	MT
Aurora Spine Corporation Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study	23-06-28	CI
Transcript : Aurora Spine Corporation, Q1 2023 Earnings Call, May 24, 2023	23-05-24
Aurora Spine Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22	CI
Transcript : Aurora Spine Corporation, Q4 2022 Earnings Call, May 01, 2023	23-05-01
Aurora Spine Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-28	CI
Aurora Spine Corporation Auditor Raises 'Going Concern' Doubt	23-04-27	CI
Aurora Spine Corporation to Showcase SiLO TFXTM SI Fusion System At American Association of Neurological Surgeons Annual Scientific Meeting	23-04-19	CI
Aurora Spine Announces Initial Surgeries Conducted Using its Sacroiliac Joint Fixation System	23-04-17	MT
Aurora Spine Receives IRB Multi-Site Selection Approval for its DEXA-C Cervical Interbody System	23-04-04	MT

Chart Aurora Spine Corporation

Duration

Period

More charts

Company Profile

Aurora Spine Corporation is a designer and manufacturer of medical devices. The Company is engaged in the development and distribution of minimally invasive, interspinous fusion systems and devices. Its product line includes implants, surgical tools and biologics. Its implants include Cervical Products, Thoraco-Lumbar Products, and SI joint products. The surgical tools include Anterior Disc Prep, Posterior Disc Prep and Compass 4D Retractor System. The biologics consist of ZIP Graft and SiLO Si-Fusion. The Company is focused on DEXA technology, which opens up treatment for osteoporotic patients. It offers DEXA-C Cervical Implants Featuring Visual Density Markers, and DEXA -L Standalone Anterior Lumbar Interbody Fusion System.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-04-25 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
AURORA SPINE CORPORATION	-25.00%	16.71M
ABBOTT LABORATORIES	-4.56%	184B
MEDTRONIC PLC	-4.59%	105B
BECTON, DICKINSON AND COMPANY	-5.32%	67.09B
DEXCOM, INC.	+8.19%	51.61B
CENCORA, INC.	+15.06%	47.55B
HOYA CORPORATION	+0.60%	39.95B
WEST PHARMACEUTICAL SERVICES, INC.	+7.12%	27.62B
SARTORIUS STEDIM BIOTECH	-12.48%	25.74B
METTLER-TOLEDO INTERNATIONAL, INC.	-1.27%	25.62B

Other Medical Equipment, Supplies & Distribution